MedCity Update – January 2018
To view this email in a web browser, go here
Sarah Haywood

Welcome – Sarah Haywood, CEO, MedCity

Hello – here is the first MedCity update for 2018. I have been contemplating how long you can continue to wish people a happy new year, but as it is still just about January; Happy New Year!

We started the year with a trip to JP Morgan Week in San Francisco as Eliot chaired a panel with the BIA and Genomics England on ‘Generation Genome’ to highlight the UK’s leadership in genomics. Today, I spoke at the Festival of Genomics where I presented our showcase report on the genomics ecosystem in the Golden Triangle.

We co-hosted the 4th Annual Future of Healthcare Investor Forum with the London Stock Exchange last week, where the pace of scientific breakthroughs and continued growth of the sector was celebrated. See if you can spot me above as Exchequer Secretary to the Treasury, Robert Jenrick MP, opened the exchange. 

I attended a Cambridge University Health Partners showcase event at Homerton College this month, which highlighted the city as world-leading for life sciences. It was great to hear about the growth of the biomedical campus and the innovations coming out of AstraZeneca, AbCam and MRC’s Laboratory of Molecular Biology, as well as what is needed to continue the growth – including making the process for industry-academic collaborations smoother, increased data sharing and more basic R&D funding.

Congratulations to the DigitalHealth.London Accelerator companies that are garnering further recognition at the moment. Eight companies, including InHealthcare, Lumeon and LiveSmart, were recognised in the Journal of mHealth’s Annual Global Digital Health 100 list this month and Andiamo was in the spotlight for their $500k win at the WeWork Creator Awards. Remember that applications for DigitalHealth.London Accelerator Cohort 3 will open on 26 February and you can sign up for the information day here.  


As ever, there are lots of events and funding opportunities available at the moment – don’t forget to scroll down to the end of the newsletter to ensure you don’t miss these. In particular, you may wish to sign up for our NIHR Biomedical Research Centre Showcase, focused on cell and gene therapy, which is taking place in London on 15 March. Finally, I’d like to welcome Elias Zapantis, our new Collaborate to Innovate Programme Manager, to the team – you can contact him at or +44 (0)20 3179 8104.

The Genomics Revolution in the Golden Triangle

MedCity and London & Partners launched its report around the region’s genomics ecosystem today; highlighting the companies and research centres designing precision clinical trials, identifying disease, and developing new life-changing treatments. Get in touch with us to find out more about the opportunities.

Read the report 


Want to access cell and gene therapy research expertise?

Join us as we present the eight NIHR Biomedical Research Centres (BRC) from across the region, along with the Cell and Gene Therapy Catapult, at our showcase event on 15 March. Register below to hear from and network with the BRCs and find out about their capabilities along the therapy development pathway.

 Find out more and register

Cambridge showcases its expertise

Cambridge Health Partners hosted their showcase event on ‘How has Cambridge become the Capital of UK Life Science?’ this month. Hosted by Malcolm Lowe-Lauri, see the talks here from Abcam, MRC LMB and AstraZeneca, who highlighted their successes in the city.

View the slides here 

Smarter London

London – the Smartest City in the World?

Theo Blackwell, the Mayor of London’s Chief Digital Officer, has started a listening exercise for a new ‘Smart London Plan’. He wants your thoughts on how we approach city growth pressures with data and digital technologies.

See Theo’s Long Read

2017: Record year for life sciences investment

This month the UK’s life sciences investment boom was highlighted in reports by MedCity, the London Stock Exchange and the BioIndustry Association. It highlighted that London led Europe for life sciences investment in 2017, IPOs and further on offerings on the LSEG increased by 20% on 2016, and the UK has the strongest pipeline in Europe across all preclinical and clinical stages.

Find out more in the reports >>>

MedCity: Record Life Sciences Investment

BIA: Pipeline Progressing – the UK’s global bioscience cluster

London Stock Exchange: Strength of UK Life Sciences

Haematology centre

New Centre for Haematology in Oxford

A new virtual centre by the University of Oxford and the Oxford University Hospitals NHS Foundation Trust is bringing together researchers and clinicians working in haematology to improve the understanding and treatment of blood diseases and disorders.

Find out more here 


Space & support in East London for overseas companies 

london-east uk has developed a new ‘Launchpad’ scheme for international companies to access free lab or office space for three months whilst they explore the life sciences ecosystem.

Find out more & apply


Launched in April 2014, MedCity is a collaboration between the Mayor of London, Imperial College Academic Health Science Centre, King’s Health Partners, UCL Partners, Cambridge University Health Partners and Oxford Academic Health Science Centre. 

The next edition of MedCity Update will be sent in February 2018.

©2017 MedCity. All rights reserved.